From CLL to Multiple Myeloma - Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration

被引：7
|
作者：
Lorenz, Joschka [1 ]
Waldschmidt, Johannes [1 ]
Wider, Dagmar [1 ]
Follo, Marie [1 ]
Ihorst, Gabriele [2 ]
Chatterjee, Manik [3 ]
May, Annette M. [4 ]
Duyster, Justus [1 ]
Rosenwald, Andreas [5 ]
Waesch, Ralph [1 ]
Zirlik, Katja [1 ]
Engelhardt, Monika [1 ]
机构：
[1] Univ Med Ctr Freiburg, Dept Haematol Oncol & Stem Cell Transplantat, Freiburg, Germany
[2] Univ Med Ctr Freiburg, Clin Trials Ctr, Freiburg, Germany
[3] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany
[4] Univ Freiburg Med Ctr, Inst Pathol, Freiburg, Germany
[5] Univ Hosp Wurzburg, Inst Pathol, Wurzburg, Germany
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2016年 / 174卷 / 06期
关键词：
multiple myeloma; chronic lymphocytic leukemia; spleen tyrosine kinase; R406; therapy; CHRONIC LYMPHOCYTIC-LEUKEMIA; INHIBITION;
D O I：
10.1111/bjh.13825
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：985 / 989
页数：6
相关论文
共 50 条
  • [31] Cytogenetic characterisation in a patient with concomitant multiple myeloma and CLL
    Ladon, Dariusz
    Kontou, T.
    Devereux, S.
    Schey, S.
    Czepulkowski, B.
    Mufti, G. J.
    JOURNAL OF MEDICAL GENETICS, 2008, 45 : S96 - S96
  • [32] TARGETING NEUROPILIN-1 IN CLL AND MULTIPLE MYELOMA
    Napoletano, S.
    Harmey, J.
    Quinn, J.
    Murphy, P.
    HAEMATOLOGICA, 2012, 97 : 377 - 378
  • [33] Angiogenin supports multiple myeloma cell migration and invasion.
    Yang, HH
    Chen, H
    Zheng, ZH
    Ong, JM
    Li, GX
    Hirsch, S
    Yan, X
    Zhu, D
    Vescio, RA
    Sharifi, BG
    Berenson, JR
    BLOOD, 2002, 100 (11) : 606A - 606A
  • [34] Potent inhibition of multiple myeloma cell migration by lovastatin.
    Morgan, MA
    Sebil, T
    Ganser, A
    Reuter, CWM
    BLOOD, 2003, 102 (11) : 443A - 444A
  • [35] The effects of thalidomide on chemotactic migration of multiple myeloma cell lines
    Fuchida, S. -I.
    Shimazaki, C.
    Hirai, H.
    Akamatsu, S.
    Yamada, N.
    Uchida, R.
    Okano, A.
    Okamoto, M.
    Inaba, T.
    Taniwaki, M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 (03) : 220 - 229
  • [36] Threonine and tyrosine kinase promotes multiple myeloma progression by regulating regucalcin expression
    Zhu, Xiaofeng
    Feng, Zuxi
    Peng, Xiaohuan
    Di, Tianning
    Li, Yanhong
    Bai, Jun
    Ma, Tao
    Li, Lijuan
    Zhang, Liansheng
    EXPERIMENTAL CELL RESEARCH, 2025, 446 (02)
  • [37] HIGH SURVIVAL IN MULTIPLE-MYELOMA
    ANTIPOVA, LG
    ANDREEVA, NE
    TERAPEVTICHESKII ARKHIV, 1985, 57 (07) : 11 - 14
  • [38] Multiple myeloma cell survival relies on high activity of protein kinase CK2
    Piazza, Francesco A.
    Ruzzene, Maria
    Gurrieri, Carmela
    Montini, Barbara
    Bonanni, Luca
    Chioetto, Gino
    Di Maira, Giovanni
    Barbon, Francesca
    Cabrelle, Anna
    Zambello, Renato
    Adami, Fausto
    Trentin, Livio
    Pinna, Lorenzo A.
    Semenzato, Gianpietro
    BLOOD, 2006, 108 (05) : 1698 - 1707
  • [39] A pleiotropy scan on multiple myeloma survival
    Macauda, Angelica
    Clay-Gilmour, Alyssa
    Morelli, Federica
    Hielscher, Thomas
    Sainz, Juan
    Weinhold, Niels
    Foersti, Asta
    Hemminki, Kari
    Goldschmidt, Hartmut
    Vachon, Celine
    Campa, Daniele
    Canzian, Federico
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S73 - S74
  • [40] Daratumumab improves survival in multiple myeloma
    Baker, Holly
    LANCET ONCOLOGY, 2016, 17 (11): : E480 - E480
12345